Equity Analysis

Key Financial Ratios
    Bliss GVS Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    506197
    INE416D01022
    97.2888746
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    BLISSGVS
    17.12
    1384.72
    EPS(TTM)
    Face Value()
    Div & Yield %:
    7.68
    1
    0.38
     
   ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.080.100.110.130.13
Long Term Debt-Equity Ratio0.050.040.040.050.05
Current Ratio5.004.094.074.555.18
Fixed Assets1.511.822.642.252.97
Inventory7.407.297.326.457.66
Debtors1.521.481.681.241.18
Interest Cover Ratio20.1012.5030.2622.7619.39
PBIDTM (%)23.1823.5522.7223.4531.04
PBITM (%)19.2921.0220.5420.4929.04
PBDTM (%)22.2221.8722.0422.5529.54
CPM (%)16.4616.8216.7417.4622.89
APATM (%)12.5714.2914.5614.5020.89
ROCE (%)11.1912.8114.5911.7117.64
RONW (%)7.919.5611.539.3814.36